Biogen has made a $15 million investment in digital health company TheraPanacea, which will go…
Patients in Wales with a rare disease that causes epilepsy will be the first in…
Incyte could be a few month away from a second FDA approval for its Opzelura…
Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered…
Australian biotech group CSL has agreed a deal to acquire Swiss drugmaker Vifor Pharma in…
Digital health startup Cadence has reached a heady $1 billion valuation just a few months…
Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years…
Novartis as opted out of a collaboration with Mesoblast to develop its stem cell-based therapy…
Define-XML is the metadata that describes the content and formatting of submission datasets and the case…
Gilead Sciences has taken a big step towards positioning its CAR-T therapy Yescarta as an…
Robert Califf looks set to take a second term as FDA commissioner after navigating a…